China News Service, Shanghai, November 2 (Li Qiuying, Li Jiajia) The 9th China International Import Expo will be held at the National Convention and Exhibition Center (Shanghai) from November 5 to 10. It is reported that a total of 162 countries, regions and international organizations participated in this CIIE, and nearly 200 "full attendance" companies and institutions participated in the exhibition for nine consecutive years. For these "full-time students", the CIIE is no longer just a window for displaying new products. Behind the nine consecutive years of attendance is a group of multinational companies that are focusing more on R&D, production and cooperation in China.
For local innovation, the first thing to be implemented is the physical layout of R&D and production. The ninth "Quality Student" Siemens Healthineers brought the world's first intelligent ring-shaped personalized radiotherapy platform and other products. It already has six R&D and production bases and two global innovation centers in China. A total of more than 150 products have been developed and produced locally, and the localization rate of the supply chain exceeds 80%.
In addition to the scale of the layout, what is more worthy of attention is the change in model. Bayer brought nearly 30 first exhibitions, debuts and local development results this year. Wang Su, Vice President of Public and Government Affairs and Sustainable Development of Bayer China, said in an interview: "In recent years, our layout in China has been further shifting from 'introducing products' to 'open innovation', continuing to strengthen local R&D, production and supply capabilities, and joining hands with Chinese partners to participate in the entire process of R&D, transformation and application earlier and more deeply." In the past eight years, Bayer has promoted the implementation of 17 "CIIE babies", and its MEDRAD Stellant The D-CE high-pressure injection system will be produced locally in 2025.
Terumo will participate in the exhibition for the ninth consecutive year this year with the theme of "Serving Patients, Advancing with China", focusing on displaying products such as MasterEX guide wires and AZUR detachable spring coils produced in China. Terumo China General Representative Yano Jingyasu said: "This year, we hope to leverage the synergy of the 'One Terumo' group, combine global technical experience with local Chinese R&D, and work with partners to explore products and solutions that meet China's clinical needs."
As R&D and manufacturing expand outward, the boundaries of local innovation are also extending toward co-creation. L'Oréal, who is also a nine-time "Quality Student", will use "The Odyssey of Beauty" as its theme this year. Its large-scale art installation "Dragon and Phoenix Goddess of Beauty" will make its world debut. The core of it is an AI-generated video of 2 minutes and 30 seconds. The Kérastase Paris K-SPA "theatre-level" care equipment used in its "Hairdressing Intelligence Research Station" area was co-created by L'Oréal's China R&D team and Chinese start-ups.
Novartis, the ninth “Quality Student”, has located its industrialization base in Pudong. In October this year, the construction of Nuoshang Life Sciences Industrialization Base in Zhangjiang, Shanghai started. The project, with a total investment of approximately 1.8 billion yuan, will be open to companies in the life science fields such as innovative drugs and medical devices, and will support diversified industrial activities such as innovation, research and development, and production services. It will provide settled enterprises with full-chain space support from pilot testing to production, help open up key links from laboratory research and development to large-scale production, and accelerate the industrialization of innovative results. This project has also been defined by Novartis as an important milestone in deepening China's development and promoting industrial innovation and development.
From producing in China, to co-creating with China, to building laboratories in China, multinational companies are connecting global technology with Chinese needs and local R&D earlier. As a key platform for high-level opening up, the CIIE is helping multinational companies grow from initial product importers to important forces deeply involved in China's local R&D, manufacturing, and industrial collaboration.
